JPMorgan Downgrades Acorda Therapeutics (ACOR) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. GNK
6. HTFL
7. SNDK
8. DVLT
9. ADYYF
10. WDAY

January 23, 2012 8:25 AM EST
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%

Rating Summary:
    4 Buy, 12 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
JPMorgan downgraded Acorda Therapeutics (NASDAQ: ACOR) from Overweight to Neutral, price target lowered from $38 to $30.

For an analyst ratings summary and ratings history on Acorda Therapeutics click here. For more ratings news on Acorda Therapeutics click here.

Shares of Acorda Therapeutics closed at $25.42 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

JPMorgan